Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors

Alireza Basiri, Michelle Xiao, Alec McCarthy, Debashis Dutta, Siddappa Nagadenahalli Byrareddy, Martin Conda Sheridan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder affecting 35 million people worldwide. A common strategy to improve the well-being of AD patients consists on the inhibition of acetylcholinesterase with the concomitant increase of the neurotransmitter acetylcholine at cholinergic synapses. Two series of unreported N-benzylpiperidines 5(a–h) and thiazolopyrimidines 9(a–q) molecules were synthesized and evaluated in vitro for their acetylcholinesterase (AChE) inhibitory activities. Among the newly synthesized compounds, 5h, 9h, 9j, and 9p displayed higher AChE enzyme inhibitory activities than the standard drug, galantamine, with IC50values of 0.83, 0.98, and 0.73 μM, respectively. Cytotoxicity studies of 5h, 9h, 9j, 9n and 9p on human neuroblastoma cells SH-SY5Y, showed no toxicity up to 40 μM concentration. Molecular docking simulations of the active compounds 5h and 9p disclosed the crucial role of π-π-stacking in their binding interaction to the active site AChE enzyme. The presented compounds have potential as AChE inhibitors and potential AD drugs.

Original languageEnglish (US)
Pages (from-to)228-231
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume27
Issue number2
DOIs
StatePublished - Jan 1 2017

Fingerprint

Piperidones
Cholinesterase Inhibitors
Acetylcholinesterase
Alzheimer Disease
Molecular Docking Simulation
Galantamine
Enzyme activity
Enzymes
Cytotoxicity
Neuroblastoma
Neurodegenerative Diseases
Pharmaceutical Preparations
Synapses
Cholinergic Agents
Acetylcholine
Neurotransmitter Agents
Toxicity
Catalytic Domain
Molecules

Keywords

  • AChE activity
  • Cytotoxicity
  • Molecular modeling
  • N-Benzylpiperidines
  • SH-SY5Y cell
  • Thiazolopyrimidinium
  • π-π-Stacking interactions

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors. / Basiri, Alireza; Xiao, Michelle; McCarthy, Alec; Dutta, Debashis; Byrareddy, Siddappa Nagadenahalli; Conda Sheridan, Martin.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 27, No. 2, 01.01.2017, p. 228-231.

Research output: Contribution to journalArticle

@article{904479d3eb5e4b43b1a04dc8f9db6708,
title = "Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors",
abstract = "Alzheimer's disease (AD) is a neurodegenerative disorder affecting 35 million people worldwide. A common strategy to improve the well-being of AD patients consists on the inhibition of acetylcholinesterase with the concomitant increase of the neurotransmitter acetylcholine at cholinergic synapses. Two series of unreported N-benzylpiperidines 5(a–h) and thiazolopyrimidines 9(a–q) molecules were synthesized and evaluated in vitro for their acetylcholinesterase (AChE) inhibitory activities. Among the newly synthesized compounds, 5h, 9h, 9j, and 9p displayed higher AChE enzyme inhibitory activities than the standard drug, galantamine, with IC50values of 0.83, 0.98, and 0.73 μM, respectively. Cytotoxicity studies of 5h, 9h, 9j, 9n and 9p on human neuroblastoma cells SH-SY5Y, showed no toxicity up to 40 μM concentration. Molecular docking simulations of the active compounds 5h and 9p disclosed the crucial role of π-π-stacking in their binding interaction to the active site AChE enzyme. The presented compounds have potential as AChE inhibitors and potential AD drugs.",
keywords = "AChE activity, Cytotoxicity, Molecular modeling, N-Benzylpiperidines, SH-SY5Y cell, Thiazolopyrimidinium, π-π-Stacking interactions",
author = "Alireza Basiri and Michelle Xiao and Alec McCarthy and Debashis Dutta and Byrareddy, {Siddappa Nagadenahalli} and {Conda Sheridan}, Martin",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.bmcl.2016.11.065",
language = "English (US)",
volume = "27",
pages = "228--231",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors

AU - Basiri, Alireza

AU - Xiao, Michelle

AU - McCarthy, Alec

AU - Dutta, Debashis

AU - Byrareddy, Siddappa Nagadenahalli

AU - Conda Sheridan, Martin

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Alzheimer's disease (AD) is a neurodegenerative disorder affecting 35 million people worldwide. A common strategy to improve the well-being of AD patients consists on the inhibition of acetylcholinesterase with the concomitant increase of the neurotransmitter acetylcholine at cholinergic synapses. Two series of unreported N-benzylpiperidines 5(a–h) and thiazolopyrimidines 9(a–q) molecules were synthesized and evaluated in vitro for their acetylcholinesterase (AChE) inhibitory activities. Among the newly synthesized compounds, 5h, 9h, 9j, and 9p displayed higher AChE enzyme inhibitory activities than the standard drug, galantamine, with IC50values of 0.83, 0.98, and 0.73 μM, respectively. Cytotoxicity studies of 5h, 9h, 9j, 9n and 9p on human neuroblastoma cells SH-SY5Y, showed no toxicity up to 40 μM concentration. Molecular docking simulations of the active compounds 5h and 9p disclosed the crucial role of π-π-stacking in their binding interaction to the active site AChE enzyme. The presented compounds have potential as AChE inhibitors and potential AD drugs.

AB - Alzheimer's disease (AD) is a neurodegenerative disorder affecting 35 million people worldwide. A common strategy to improve the well-being of AD patients consists on the inhibition of acetylcholinesterase with the concomitant increase of the neurotransmitter acetylcholine at cholinergic synapses. Two series of unreported N-benzylpiperidines 5(a–h) and thiazolopyrimidines 9(a–q) molecules were synthesized and evaluated in vitro for their acetylcholinesterase (AChE) inhibitory activities. Among the newly synthesized compounds, 5h, 9h, 9j, and 9p displayed higher AChE enzyme inhibitory activities than the standard drug, galantamine, with IC50values of 0.83, 0.98, and 0.73 μM, respectively. Cytotoxicity studies of 5h, 9h, 9j, 9n and 9p on human neuroblastoma cells SH-SY5Y, showed no toxicity up to 40 μM concentration. Molecular docking simulations of the active compounds 5h and 9p disclosed the crucial role of π-π-stacking in their binding interaction to the active site AChE enzyme. The presented compounds have potential as AChE inhibitors and potential AD drugs.

KW - AChE activity

KW - Cytotoxicity

KW - Molecular modeling

KW - N-Benzylpiperidines

KW - SH-SY5Y cell

KW - Thiazolopyrimidinium

KW - π-π-Stacking interactions

UR - http://www.scopus.com/inward/record.url?scp=85006961062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006961062&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2016.11.065

DO - 10.1016/j.bmcl.2016.11.065

M3 - Article

C2 - 27914796

AN - SCOPUS:85006961062

VL - 27

SP - 228

EP - 231

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 2

ER -